Par Launches Generic Atacand HCT Tablets
Atacand HCT is indicated for the treatment of hypertension and may be substituted for titrated components, but is not for initial therapy. It is a combination of candesartan cilexetil, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic.
Candesartan and Hydrochlorothiazide Tablets are available in 16mg/12.5mg, 32mg/12.5mg, and 32mg/25mg dosage strengths. Par has begun shipment of these products.
For more information call (800) 828-9393 or visit www.parpharm.com.